Drug Shortage Report for AURO-TELMISARTAN
| Report ID | 70336 |
| Drug Identification Number | 02453568 |
| Brand name | AURO-TELMISARTAN |
| Common or Proper name | Telmisartan |
| Company Name | AURO PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TELMISARTAN |
| Strength(s) | 40MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2018-12-20 |
| Estimated end date | |
| Actual end date | 2019-07-16 |
| Shortage status | Resolved |
| Updated date | 2019-07-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
| Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2019-07-17 | French | Compare |
| v5 | 2019-07-17 | English | Compare |
| v4 | 2019-01-14 | French | Compare |
| v3 | 2019-01-14 | English | Compare |
| v2 | 2018-12-21 | French | Compare |
| v1 | 2018-12-21 | English | Compare |
Showing 1 to 6 of 6